Akero Therapeutics (AKRO) Income Statement (2018 - 2025)
Income Statement report data from Mar 31, 2018 to Sep 30, 2025 for Akero Therapeutics (AKRO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||||||||
Research And Development | 79M (+13.91%) | 69M (-0.46%) | 70M | - | 72M (+30.57%) | 55M (+9.22%) | 51M | - | 39M (+38.01%) | 28M (+28.45%) | 22M (+18.94%) | 18M (-26.98%) | 25M (+17.46%) | 21M (+4.14%) | 21M (-25.98%) | 28M (+42.32%) | 19M (-18.81%) | 24M (+126.23%) | 11M | - | 17M (+33.28%) | 13M (+48.35%) | 8.79M (-33.11%) | 13M (-5.40%) | 14M (+133.05%) | 5.96M (+46.80%) | 4.06M | - | 1.25M (-85.15%) | 8.42M | - |
Selling General And Administrative | 11M (-2.32%) | 12M (+2.65%) | 11M | - | 9.47M (-9.12%) | 10M (+12.04%) | 9.30M | - | 7.98M (+4.45%) | 7.64M (+9.61%) | 6.97M (-1.83%) | 7.10M (-35.45%) | 11M (+76.57%) | 6.23M (+12.45%) | 5.54M (+17.12%) | 4.73M (-3.07%) | 4.88M (-2.20%) | 4.99M (+10.15%) | 4.53M | - | 4.16M (+21.64%) | 3.42M (-4.74%) | 3.59M (+16.56%) | 3.08M (+27.27%) | 2.42M (+46.67%) | 1.65M (+13.79%) | 1.45M | - | 470K (+95.83%) | 240K | - |
Operating Expenses | 90M (+11.59%) | 81M (-0.01%) | 81M | - | 82M (+24.28%) | 66M (+9.66%) | 60M | - | 47M (+30.84%) | 36M (+23.93%) | 29M (+13.10%) | 25M (-29.56%) | 36M (+30.81%) | 28M (+5.91%) | 26M (-19.70%) | 32M (+33.22%) | 24M (-15.95%) | 29M (+91.47%) | 15M | - | 22M (+30.94%) | 16M (+32.88%) | 12M (-23.67%) | 16M (-0.55%) | 16M (+114.32%) | 7.61M (+38.11%) | 5.51M | - | 1.73M (-80.02%) | 8.66M | - |
Depreciation And Amortization | - | - | - | - | - | - | - | - | - | - | 10K (-66.67%) | 30K | - | - | 10K (-66.67%) | 30K | - | - | 10K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||||||||||
Operating Income | -90.24M (+11.59%) | -80.87M (-0.01%) | -80.88M | - | -81.70M (+24.28%) | -65.74M (+9.66%) | -59.95M | - | -46.61M (+30.82%) | -35.63M (+23.93%) | -28.75M (+13.10%) | -25.42M (-29.56%) | -36.09M (+30.81%) | -27.59M (+5.91%) | -26.05M (-19.70%) | -32.44M (+33.22%) | -24.35M (-15.95%) | -28.97M (+91.47%) | -15.13M | - | -21.54M (+30.94%) | -16.45M (+32.88%) | -12.38M (-23.67%) | -16.22M (-0.55%) | -16.31M (+114.32%) | -7.61M (+38.11%) | -5.51M | - | -1.73M (-80.02%) | -8.66M | - |
Ebit | -90.24M (+11.59%) | -80.87M (-0.01%) | -80.88M (-67.91%) | -252.06M (+208.52%) | -81.70M (+24.28%) | -65.74M (+9.66%) | -59.95M (-60.50%) | -151.76M (+225.60%) | -46.61M (+30.82%) | -35.63M (+23.93%) | -28.75M (+13.10%) | -25.42M (-29.56%) | -36.09M (+30.81%) | -27.59M (+5.91%) | -26.05M (-19.70%) | -32.44M (+33.22%) | -24.35M (-15.95%) | -28.97M (+91.47%) | -15.13M (-80.90%) | -79.21M (+267.73%) | -21.54M (+30.94%) | -16.45M (+32.88%) | -12.38M (-23.67%) | -16.22M (-0.55%) | -16.31M (+114.32%) | -7.61M (+38.11%) | -5.51M (-93.26%) | -81.71M (+4623.12%) | -1.73M (-80.02%) | -8.66M (+1961.90%) | -420.00K |
EBITDA | -80.47M (+16.07%) | -69.33M (-0.34%) | -69.57M (-72.40%) | -252.06M (+252.73%) | -71.46M (+30.50%) | -54.76M (-8.66%) | -59.95M (-60.50%) | -151.76M (+291.44%) | -38.77M (+28.25%) | -30.23M (+5.18%) | -28.74M (+8.45%) | -26.50M (-24.76%) | -35.22M (+28.78%) | -27.35M (+5.03%) | -26.04M (-19.80%) | -32.47M (+33.46%) | -24.33M (-15.90%) | -28.93M (+91.34%) | -15.12M (-80.91%) | -79.21M (+270.14%) | -21.40M (+32.02%) | -16.21M (+36.33%) | -11.89M (-23.73%) | -15.59M (+0.26%) | -15.55M (+115.08%) | -7.23M (+34.89%) | -5.36M (-93.44%) | -81.71M (+632.83%) | -11.15M (+28.60%) | -8.67M (+1964.29%) | -420.00K |
Other Income / Expenses | |||||||||||||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 140K (-44.00%) | 250K (-48.98%) | 490K | -1.30M | 760K (+100.00%) | 380K (+123.53%) | 170K | - | - | - | - |
Interest Expense | 1.09M (-6.84%) | 1.17M (+1.74%) | 1.15M | - | 1.25M (+1.63%) | 1.23M (+24.24%) | 990K | - | 890K (+3.49%) | 860K (+86.96%) | 460K (+27.78%) | 360K (+12.50%) | 320K (+540.00%) | 50K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | -1.09M (-6.84%) | -1.17M (+1.74%) | -1.15M | - | -1.25M (+1.63%) | -1.23M (+24.24%) | -990.00K | - | -890.00K (+3.49%) | -860.00K (+86.96%) | -460.00K (+27.78%) | -360.00K (+12.50%) | -320.00K (+540.00%) | -50.00K | - | - | - | - | - | - | 140K (-44.00%) | 250K (-48.98%) | 490K | -1.30M | 760K (+100.00%) | 380K (+123.53%) | 170K | - | - | - | - |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 140K (-44.00%) | 250K (-48.98%) | 490K (-74.21%) | 1.90M (+150.00%) | 760K (+100.00%) | 380K (+153.33%) | 150K | - | -9.42M (+94100.00%) | -10.00K | - |
Net Income | |||||||||||||||||||||||||||||||
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -81.57M (+15.70%) | -70.50M (-0.31%) | -70.72M (-71.94%) | -252.06M (+246.71%) | -72.70M (+29.84%) | -55.99M (+4.97%) | -53.34M (-64.85%) | -151.76M (+282.65%) | -39.66M (+27.61%) | -31.08M (+20.33%) | -25.83M (+12.01%) | -23.06M (-35.12%) | -35.54M (+29.71%) | -27.40M (+5.26%) | -26.03M (-19.71%) | -32.42M (+33.25%) | -24.33M (-15.90%) | -28.93M (+91.72%) | -15.09M (-80.95%) | -79.21M (+270.14%) | -21.40M (+32.02%) | -16.21M (+36.33%) | -11.89M (-23.83%) | -15.61M (+0.39%) | -15.55M (+115.08%) | -7.23M (+34.89%) | -5.36M (-93.44%) | -81.71M (+632.83%) | -11.15M (+28.60%) | -8.67M (+1964.29%) | -420.00K |
Net Income | -81.57M (+15.70%) | -70.50M (-0.31%) | -70.72M (-71.94%) | -252.06M (+246.71%) | -72.70M (+29.84%) | -55.99M (+4.97%) | -53.34M (-64.85%) | -151.76M (+282.65%) | -39.66M (+27.61%) | -31.08M (+20.33%) | -25.83M (+12.01%) | -23.06M (-35.12%) | -35.54M (+29.71%) | -27.40M (+5.26%) | -26.03M (-19.71%) | -32.42M (+33.25%) | -24.33M (-15.90%) | -28.93M (+91.72%) | -15.09M (-80.95%) | -79.21M (+270.14%) | -21.40M (+32.02%) | -16.21M (+36.33%) | -11.89M (-23.83%) | -15.61M (+0.39%) | -15.55M (+115.08%) | -7.23M (+34.89%) | -5.36M (-93.44%) | -81.71M (+632.83%) | -11.15M (+28.60%) | -8.67M (+1964.29%) | -420.00K |
Comprehensive Income Net Of Tax | -80.73M (+14.35%) | -70.60M (+0.01%) | -70.59M | - | -70.34M (+25.23%) | -56.17M (+4.62%) | -53.69M | - | -39.91M (+27.30%) | -31.35M (+21.28%) | -25.85M (-76.91%) | -111.97M (+215.05%) | -35.54M (+29.80%) | -27.38M (+5.19%) | -26.03M (-74.18%) | -100.80M (+314.13%) | -24.34M (-15.89%) | -28.94M (+91.78%) | -15.09M | - | -21.48M (+32.92%) | -16.16M (+36.60%) | -11.83M (-72.97%) | -43.76M (+181.41%) | -15.55M (+115.08%) | -7.23M (+34.89%) | -5.36M | - | - | - | - |